Credit Agricole S A Purchases 5,140 Shares of Cardinal Health, Inc. $CAH

Key Points

• Credit Agricole S A increased its holdings in Cardinal Health, Inc. by 8.0% during the first quarter, now owning 69,513 shares valued at approximately $9.58 million.
• Insider sales occurred recently, with CEO Jason M. Hollar selling 107,705 shares and insider Jessica L. Mayer selling 38,078 shares on August 19th.
• Analysts have mixed views, with target prices being adjusted; however, the consensus remains a "Moderate Buy" with an average target price of $163.20.

Credit Agricole S A increased its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 8.0% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 69,513 shares of the company's stock after acquiring an additional 5,140 shares during the quarter. Credit Agricole S A's holdings in Cardinal Health were worth $9,577,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of CAH. NewEdge Advisors LLC grew its holdings in shares of Cardinal Health by 5.3% during the fourth quarter. NewEdge Advisors LLC now owns 12,429 shares of the company's stock valued at $1,470,000 after buying an additional 622 shares in the last quarter. First Trust Advisors LP grew its stake in Cardinal Health by 39.9% in the fourth quarter. First Trust Advisors LP now owns 222,764 shares of the company's stock valued at $26,346,000 after purchasing an additional 63,535 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in Cardinal Health by 1.2% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,238,848 shares of the company's stock valued at $146,517,000 after purchasing an additional 15,212 shares in the last quarter. Tower Research Capital LLC TRC grew its stake in Cardinal Health by 40.8% in the fourth quarter. Tower Research Capital LLC TRC now owns 13,342 shares of the company's stock valued at $1,578,000 after purchasing an additional 3,869 shares in the last quarter. Finally, TD Waterhouse Canada Inc. grew its stake in Cardinal Health by 253.0% in the fourth quarter. TD Waterhouse Canada Inc. now owns 2,358 shares of the company's stock valued at $279,000 after purchasing an additional 1,690 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of brokerages have commented on CAH. Morgan Stanley restated an "overweight" rating on shares of Cardinal Health in a research note on Tuesday, August 12th. UBS Group reaffirmed a "buy" rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Robert W. Baird boosted their price target on Cardinal Health from $197.00 to $203.00 and gave the stock an "outperform" rating in a research report on Wednesday, August 13th. Wells Fargo & Company reaffirmed an "overweight" rating and issued a $185.00 price target (up previously from $183.00) on shares of Cardinal Health in a research report on Wednesday, August 13th. Finally, Citigroup reaffirmed a "neutral" rating and issued a $170.00 price target (up previously from $157.00) on shares of Cardinal Health in a research report on Friday, June 13th. Twelve equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $163.20.

Cardinal Health Trading Down 2.3%

NYSE CAH traded down $3.5270 during trading hours on Friday, reaching $148.0430. 2,685,985 shares of the company's stock were exchanged, compared to its average volume of 2,600,685. The stock has a market cap of $35.35 billion, a PE ratio of 22.95, a price-to-earnings-growth ratio of 1.25 and a beta of 0.67. Cardinal Health, Inc. has a one year low of $106.54 and a one year high of $168.44. The firm has a fifty day moving average of $159.02 and a 200-day moving average of $145.58.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, beating analysts' consensus estimates of $2.03 by $0.05. The firm had revenue of $60.16 billion for the quarter, compared to analyst estimates of $60.91 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The business's quarterly revenue was up .5% compared to the same quarter last year. During the same period last year, the company earned $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, research analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be paid a $0.5107 dividend. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.4%. Cardinal Health's dividend payout ratio is 31.63%.

Insider Buying and Selling

In related news, insider Ola M. Snow sold 28,151 shares of the firm's stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the sale, the insider owned 15,431 shares of the company's stock, valued at approximately $2,298,293.14. This trade represents a 64.59% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Jessica L. Mayer sold 38,078 shares of the stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $5,666,767.96. Following the transaction, the insider owned 48,457 shares of the company's stock, valued at approximately $7,211,370.74. This trade represents a 44.00% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 271,676 shares of company stock worth $40,489,525 over the last 90 days. 0.09% of the stock is currently owned by corporate insiders.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.